6% Yield Bristol Myers Squibb Value Trap Or Long-Term Opportunity?

Ipad, Online, Tablet, Internet, Screen, Digital

Image Source: Pixabay


In this video, Chuck Carnevale, Co-Founder of FAST Graphs will go over Bristol Myers Squibb (BMY) and help determine whether BMY is a Value Trap Or a Long-Term Opportunity.

Should you invest in Bristol Myers now, this A-rated pharmaceutical giant that is offering a 6% yield and trading for less than 9 times earnings? Or is this a value trap that should be avoided at all costs?

Video Length: 00:26:49


More By This Author:

10 Super FAST Growth Stocks At A Reasonable Price (GARP)
Which Is The Best Investment For You? High Yield Pfizer Or Higher Growth Merck?
The 10 Worst Performing S&P 500 Stocks in 2023 - Are They Good Investments Now?

Disclosure: Long BMY.

Disclaimer: The opinions in this article are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments